Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
暂无分享,去创建一个
S. Chan | S. Johnston | A. Wardley | N. Davidson | S. Ashley | S. Ashley | S. Sutherland | D. Miles | R. Bhatti | M. Shehata | H. Nouras | T. Camburn | S. Johnston